EIGR Eiger Biopharmaceuticals Inc

Eiger BioPharmaceuticals Inc is a clinical stage biopharmaceutical company. It is focused on bringing to market novel product candidates for the treatment of orphan diseases.

As of 12/02/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/30/2014
Outstanding shares:  44,074,284
Average volume:  305,617
Market cap:   $198,775,021
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BDC6XM9
Valuation   (See tab for details)
PE ratio:   -2.33
PB ratio:   1.89
PS ratio:   20.54
Return on equity:   -58.15%
Net income %:   -584.36%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy